TENX

Tenax Therapeutics Inc

TENX, USA

Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

https://www.tenaxthera.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TENX
stock
TENX

Blockchain Infrastructure Company TenX Protocols Gets Listed on TSXV, Announces Over $33M CAD in Funding TheNewsCrypto

Read more →
TENX
stock
TENX

TenX Protocols Goes Public to Catalyze Institutional-Grade Growth of Next-Gen Blockchains Live Bitcoin News

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$20

Analyst Picks

Strong Buy

3

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

4.07

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-16.43 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-15.37 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.07

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 56.91% of the total shares of Tenax Therapeutics Inc

1.

RTW INVESTMENTS, LLC

(8.2925%)

since

2025/06/30

2.

Bvf Inc

(7.4422%)

since

2025/06/30

3.

Millennium Management LLC

(5.1225%)

since

2025/06/30

4.

Vivo Capital, LLC

(4.5662%)

since

2025/06/30

5.

Morgan Stanley - Brokerage Accounts

(3.9016%)

since

2025/06/30

6.

TD Health Sciences - I

(3.886%)

since

2024/12/31

7.

Integral Health Asset Management, LLC

(3.6603%)

since

2025/06/30

8.

HHG PLC

(3.653%)

since

2025/06/30

9.

ADAR1 Capital Management LLC

(3.4095%)

since

2025/06/30

10.

VR Adviser, LLC

(2.1603%)

since

2025/06/30

11.

Vanguard Total Stock Mkt Idx Inv

(2.1075%)

since

2025/07/31

12.

Velan Capital Investment Management LP

(1.8265%)

since

2025/06/30

13.

Adage Capital Partners Gp LLC

(1.8265%)

since

2025/06/30

14.

Vestal Point Capital LP

(1.1713%)

since

2025/06/30

15.

Geode Capital Management, LLC

(0.7504%)

since

2025/06/30

16.

Vanguard Institutional Extnd Mkt Idx Tr

(0.528%)

since

2025/07/31

17.

Vanguard Group Inc

(0.4885%)

since

2025/06/30

18.

Fidelity Extended Market Index

(0.393%)

since

2025/07/31

19.

Dimensional Fund Advisors, Inc.

(0.3492%)

since

2025/06/30

20.

DFA US Targeted Value I

(0.2936%)

since

2025/07/31

21.

Citadel Advisors Llc

(0.2267%)

since

2025/06/30

22.

Fidelity Total Market Index

(0.1308%)

since

2025/07/31

23.

Fidelity Series Total Market Index

(0.1065%)

since

2025/07/31

24.

NT Ext Equity Mkt Idx Fd - NL

(0.1006%)

since

2025/06/30

25.

NT Ext Equity Mkt Idx Fd - L

(0.0856%)

since

2025/06/30

26.

Northern Trust Extended Eq Market Idx

(0.0856%)

since

2025/06/30

27.

Spartan Extended Market Index Pool F

(0.0844%)

since

2025/07/31

28.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0782%)

since

2025/06/30

29.

Dimensional US Sustainability Core 1 ETF

(0.0556%)

since

2025/08/29

30.

Spartan Total Market Index Pool G

(0.0309%)

since

2025/07/31

31.

Tower Research Capital LLC

(0.0274%)

since

2025/06/30

32.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0242%)

since

2025/06/30

33.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0204%)

since

2024/12/31

34.

Fidelity Nasdaq Composite Index

(0.008%)

since

2025/07/31

35.

BlackRock Inc

(0.0066%)

since

2025/06/30

36.

Bank of America Corp

(0.0055%)

since

2025/06/30

37.

UBS Group AG

(0.0003%)

since

2025/06/30

38.

State St US Extended Mkt Indx NL Cl C

(0.0002%)

since

2025/08/31

39.

SSgA U.S. Total Market Index Strategy

(0.0001%)

since

2025/03/31

40.

Northern Trust Wilshire 5000

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.4

EPS Estimate

-0.23

EPS Difference

-0.17

Surprise Percent

-73.913%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(3)
Net Net
Strong Net-Net(7)
Quality
Low Quality Business(3)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.